{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T08:14:59Z","timestamp":1787904899257,"version":"build-2784847793"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG3DA048734"],"award-info":[{"award-number":["UG3DA048734"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["T32 DA007209"],"award-info":[{"award-number":["T32 DA007209"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jad.2021.12.004","type":"journal-article","created":{"date-parts":[[2021,12,4]],"date-time":"2021-12-04T01:47:19Z","timestamp":1638582439000},"page":"223-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"special_numbering":"C","title":["Latent trajectories of anxiety and depressive symptoms among adults in early treatment for nonmedical opioid use"],"prefix":"10.1016","volume":"299","author":[{"given":"Jennifer D.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill A.","family":"Rabinowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Wells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick H.","family":"Finan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denis G. Antoine","family":"II","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Hobelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Huhn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2021.12.004_bib0001","series-title":"Diagnostic and Statistical Manual of Mental disorders: DSM-5","year":"2013"},{"key":"10.1016\/j.jad.2021.12.004_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108028","article-title":"Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: differences in retention and completion among opioid-related discharges in 201","volume":"114","author":"Askari","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.jad.2021.12.004_bib0003","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.jad.2021.01.005","article-title":"Validation of brief screening measures for depression and anxiety in young people with substance use disorders","volume":"282","author":"Bentley","year":"2021","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2021.12.004_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108884","article-title":"Longitudinal patterns of momentary stress during outpatient opioid agonist treatment: a growth-mixture-model approach to classifying patients","author":"Burgess-Hull","year":"2021","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2021.12.004_bib0005","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.drugalcdep.2018.08.019","article-title":"Accounting for the uncounted: physical and affective distress in individuals dropping out of oral naltrexone treatment for opioid use disorder","volume":"192","author":"Carroll","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2021.12.004_bib0006","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.drugalcdep.2012.03.011","article-title":"Brief case finding tools for anxiety disorders: validation of GAD-7 and GAD-2 in addictions treatment","volume":"125","author":"Delgadillo","year":"2012","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2021.12.004_bib0007","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.addbeh.2007.09.017","article-title":"Comparing the BDI-II and the PHQ-9 with outpatient substance abusers","volume":"33","author":"Dum","year":"2008","journal-title":"Addict. Behav."},{"key":"10.1016\/j.jad.2021.12.004_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2020.108012","article-title":"Co-occurring opioid and sedative use disorder: gender differences in use patterns and psychiatric co-morbidities in the United States","volume":"114","author":"Ellis","year":"2020","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.jad.2021.12.004_bib0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1521-0391.2013.12074.x","article-title":"Predictive factors for relapse in patients on buprenorphine maintenance","volume":"23","author":"Ferri","year":"2014","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.jad.2021.12.004_bib0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/j.pain.0000000000001111","article-title":"Relationship between concomitant benzodiazepine-opioid use and adverse outcomes among US veterans","volume":"159","author":"Gressler","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.jad.2021.12.004_bib0011","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1001\/jamapediatrics.2018.2143","article-title":"Receipt of timely addiction treatment and association of early medication treatment with retention in care among youths with opioid use disorder","volume":"172","author":"Hadland","year":"2020","journal-title":"JAMA Pediatr."},{"key":"10.1016\/j.jad.2021.12.004_bib0012","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3109\/00952990.2010.535581","article-title":"Anxiety sensitivity and illicit sedative use among opiate-dependent women and men","volume":"37","author":"Hearon","year":"2011","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.jad.2021.12.004_bib0013","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/ajad.12921","article-title":"Sex-based differences in treatment outcomes for persons with opioid use disorder","volume":"28","author":"Huhn","year":"2019","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.jad.2021.12.004_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11920-020-01201-z","article-title":"Challenges for women entering treatment for opioid use disorder","volume":"22","author":"Huhn","year":"2020","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.jad.2021.12.004_bib0015","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainresbull.2016.01.012","article-title":"Ecological momentary assessment of affect and craving in patients in treatment for prescription opioid dependence","volume":"123","author":"Huhn","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jad.2021.12.004_bib0016","article-title":"Differences in availability and use of medications for opoid use disorder in residential treatment settings in the United States","volume":"5","author":"Huhn","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.jad.2021.12.004_bib0017","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.brainresbull.2015.12.004","article-title":"Evidence of anhedonia and differential reward processing in prefrontal cortex among post-withdrawal patients with prescription opiate dependence","volume":"123","author":"Huhn","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.jad.2021.12.004_bib0018","unstructured":"IBM Corp. Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp."},{"key":"10.1016\/j.jad.2021.12.004_bib0019","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/cad.20398","article-title":"Latent profile transition analyses and growth mixture models: a very non-technical guide for researchers in child and adolescent development","volume":"175","author":"Johnson","year":"2021","journal-title":"New Dir. Child Adolesc. Dev."},{"key":"10.1016\/j.jad.2021.12.004_bib0020","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2014.11.044","article-title":"The dark side of emotion: the addiction perspective","volume":"753","author":"Koob","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.jad.2021.12.004_bib0021","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J. Gen. Intern. Med."},{"key":"10.1016\/j.jad.2021.12.004_bib0022","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.genhosppsych.2010.03.006","article-title":"The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review","volume":"32","author":"Kroenke","year":"2010","journal-title":"Gen. Hosp. Psychiatry"},{"key":"10.1016\/j.jad.2021.12.004_bib0023","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s11121-016-0644-5","article-title":"Principled missing data treatments","volume":"19","author":"Lang","year":"2018","journal-title":"Prev. Sci."},{"key":"10.1016\/j.jad.2021.12.004_bib0024","article-title":"The developmental origins of opioid use disorder and its comorbidities","author":"Levin","year":"2021","journal-title":"Front. Hum. Neurosci."},{"key":"10.1016\/j.jad.2021.12.004_bib0025","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1001\/jamapsychiatry.2017.0113","article-title":"Changes in US Lifetime heroin use and heroin use disorder: prevalence from 2001 to 2002 to 2012-2013 national epidemiologic survey on alcohol and related conditions","volume":"74","author":"Martins","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.jad.2021.12.004_bib0026","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.addbeh.2016.08.020","article-title":"Anxiety sensitivity and nonmedical benzodiazepine use among adults with opioid use disorder","volume":"65","author":"McHugh","year":"2017","journal-title":"Addict. Behav."},{"key":"10.1016\/j.jad.2021.12.004_bib0027","first-page":"1","article-title":"Opioid use disorder and COVID-19: implications for policy and practice","volume":"34","author":"Mitchell","year":"2021","journal-title":"J. Am. Acad. PAs"},{"key":"10.1016\/j.jad.2021.12.004_bib0028","series-title":"Mplus User's Guide","author":"Muth\u00e9n","year":"1998-2017"},{"key":"10.1016\/j.jad.2021.12.004_bib0029","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1080\/10705510701575396","article-title":"Deciding on the number of classes in latent class analysis and growth mixture modeling: a Monte Carlo simulation study","volume":"14","author":"Nylund","year":"2007","journal-title":"Struct. Equ. Model. Multidiscip. J."},{"key":"10.1016\/j.jad.2021.12.004_bib0030","first-page":"1","article-title":"Effects of dialectical behavior therapy on emotion regulation, distress tolerance, craving, and depression in patients with opioid dependence disorder","author":"Rezaie","year":"2021","journal-title":"J. Contemp. Psychother."},{"key":"10.1016\/j.jad.2021.12.004_bib0031","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.15585\/mmwr.mm655051e1","article-title":"Increases in drug and opioid-involved overdose deaths: United States, 2010-2015","volume":"65","author":"Rudd","year":"2016","journal-title":"Morb. Mortal. Wkly. Rep."},{"key":"10.1016\/j.jad.2021.12.004_bib0032","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jpain.2011.11.004","article-title":"Concurrent use of alcohol and sedatives among persons prescribed chronic opioid therapy: prevalence and risk factors","volume":"13","author":"Saunders","year":"2012","journal-title":"J. Pain"},{"key":"10.1016\/j.jad.2021.12.004_bib0033","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108176","article-title":"Signal of increased opioid overdose during COVID-19 from emergency medical services data","volume":"214","author":"Slavova","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2021.12.004_bib0034","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","article-title":"A brief measure for assessing generalized anxiety disorder: the GAD-7","volume":"166","author":"Spitzer","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jad.2021.12.004_bib0035","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jsat.2010.05.014","article-title":"Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons","volume":"39","author":"Stein","year":"2019","journal-title":"J. Subst. Abuse Treat."},{"key":"10.1016\/j.jad.2021.12.004_bib0036","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/ajad.12554","article-title":"Perceived need for depression treatment among person entering inpatient opioid detoxification","volume":"26","author":"Stein","year":"2017","journal-title":"Am. J. Addict."},{"key":"10.1016\/j.jad.2021.12.004_bib0037","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.drugalcdep.2008.10.015","article-title":"Clinical characteristics of treatment-seeking prescription opioid vs. heroin-using adolescents with opioid use disorder","volume":"101","author":"Subramaniam","year":"2009","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2021.12.004_bib0038","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10550887.2016.1100960","article-title":"Retention in medication-assisted treatment for opiate dependence: a systematic review","volume":"35","author":"Timko","year":"2016","journal-title":"J. Addict. Dis."},{"key":"10.1016\/j.jad.2021.12.004_bib0039","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.107940","article-title":"Parallel modeling of pain and depression in prediction of relapse during buprenorphine and naloxone treatment: a finite mixture model","volume":"209","author":"Vest","year":"2020","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.jad.2021.12.004_bib0040","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.ijsu.2014.07.013","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"12","author":"Von Elm","year":"2014","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.jad.2021.12.004_bib0041","doi-asserted-by":"crossref","first-page":"288","DOI":"10.3389\/fpsyt.2017.00288","article-title":"Gender and age effects on the trajectory of depression in opioid users during methadone maintenance treatment","volume":"8","author":"Wang","year":"2017","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.jad.2021.12.004_bib0042","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1213\/ANE.0000000000002496","article-title":"Risk factors for opioid-use disorder and overdose","volume":"125","author":"Webster","year":"2017","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.jad.2021.12.004_bib0043","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.biopsych.2019.07.027","article-title":"The negative affect of protracted opioid abstinence: progress and perspectives from rodent models","volume":"87","author":"Welsch","year":"2020","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.jad.2021.12.004_bib0044","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1093\/pm\/pny179","article-title":"Correlates of benzodiazepine use and adverse outcomes among patients with chronic pain prescribed long-term opioid therapy","volume":"20","author":"Yarborough","year":"2019","journal-title":"Pain Med."},{"key":"10.1016\/j.jad.2021.12.004_bib0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2021.108996","article-title":"Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: results from a multisite trial of buprenorphine-naloxone and methadone","author":"Zhu","year":"2021","journal-title":"Drug Alcohol Depend."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721013197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032721013197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T20:20:24Z","timestamp":1777494024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032721013197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":45,"alternative-id":["S0165032721013197"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2021.12.004","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latent trajectories of anxiety and depressive symptoms among adults in early treatment for nonmedical opioid use","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2021.12.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}